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OMAGING
irst-trimester 3-dimensional power Doppler of the
teroplacental circulation space: a potential
creening method for preeclampsia
e’er Dar, MD; Juliana Gebb, MD; Laura Reimers, MPH; Peter S. Bernstein, MD, MPH;
ynthia Chazotte, MD; Irwin R. Merkatz, MDR
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KBJECTIVE: The objective of the study was to compare 3-dimensional
ower Doppler (3DPD) of the uteroplacental circulation space (UPCS) in
he first trimester between women who develop preeclampsia (PEC)
nd those who do not and to assess the 3DPD method as a screening
ool for PEC.
TUDY DESIGN: This was a prospective observational study of single-
on pregnancies at 10 weeks 4 days to 13 weeks 6 days. The 3DPD
ndices, vascularization index (VI), flow index (FI), and vascularization
ow index (VFI), were determined on a UPSC sphere biopsy with the vir-ethod for preeclampsia. Am J Obstet Gynecol 2010;203:238.e1-7.
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the intervillous space.
oi: 10.1016/j.ajog.2010.06.006
38.e1 American Journal of Obstetrics& Gynecology SEPTEMBER 2010ESULTS: Of 277 women enrolled, 24 developed PEC. The 3DPD indi-
es were lower in women who developed PEC. The area under the re-
eiver-operating characteristics curve for the prediction of PEC was
8.9%, 77.6%, and 79.6% for VI, FI, and VFI, respectively.
ONCLUSION: Patients who develop PEC have lower 3DPD indices of
heir UPCS during the first trimester. Our findings suggest that this ul-
rasonographic tool has the potential to predict the development of PEC.
ey words: 3-dimensional power Doppler, preeclampsia, screening
ual organ computer-aided analysis (VOCAL) program. tool, uteroplacental circulation space
ite this article as: Dar P, Gebb J, Reimers L, et al. First-trimester 3-dimensional power Doppler of the uteroplacental circulation space: a potential screeningm
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pormal development of the intervil-
lous space during the first trimes-
er is crucial to proper fetal-maternal
nteraction.1 Pivotal to this is the tropho-
last-mediated modification of the
mall-caliber spiral arteries into wide-
aliber uteroplacental vessels that deliver
lood to the intervillous space2 and ulti-
ately to the placenta at low pressure.
nadequatemodification of the spiral ar-
eries resulting in decreased blood flow
o the placenta has been implicated in the
athophysiology of preeclampsia.3
Advances in both ultrasound and the
nowledge of the pathophysiology of
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pen access under CC BY-NC-ND license.reeclampsia have revived attempts at
nding a screening method for the
isorder with the focus shifted to identi-
ying a screening program for the first
rimester. Current imagingmethods, in-
luding first trimester uterine artery pul-
atility index (UAPI)4 or resistive index5
nd placental volume,6 have low detec-
ion rates for preeclampsia and are im-
roved only if detection of severe cases
equiring early delivery are the focus.
his may be because these methods rep-
esent an indirect assessment of the ab-
ormal placentation process.
The addition ofmaternal serummark-
rs such as placental protein 137 and
regnancy-associated plasma protein A
PAPP-A),8 which are likely to better re-
ect the placentation process, are pre-
icted to significantly improve screening
ensitivity.9,10
The introduction of 3-dimensional
3D) ultrasound technologies, with the
ption of imaging vascular volumes,11-13
as created an excellent opportunity to
tudy early changes in the uteroplacental
irculation space (UPCS), which in-
ludes the maternal spiral arteries andtThis technology may therefore allow a
ore direct evaluation of the abnormal
lacentation process that occurs with
reeclampsia and particular findings
hat may herald the development of pre-
clampsia. In this study, we sought to:
1) compare first-trimester 3D power
oppler (3DPD) indices of the UPCS in
atients who developed preeclampsia and
hose who did not; and (2) evaluate 3DPD
f the UPCS as a potential first-trimester
creeningmethod for preeclampsia.
ATERIALS AND METHODS
e conducted a prospective observa-
ional study in singleton pregnancies. All
atients, 18 years old and older, who
ere attending our center for routine
creening for chromosomal abnormali-
ies by measurement of fetal nuchal
ranslucency (NT) thickness and mater-
al serum-free beta-human chorionic
onadotropin and PAPP-A at a gestation
f 10 weeks 4 days to 13 weeks 6 days
ere invited to participate.
The study was approved by our insti-
utional review board, and written in-
ormed consent was obtained from all
articipants. Patients with multiple ges-
ations or anomalous fetuses were ex-
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www.AJOG.org Imaging Researchluded. Patients’ demographic data were
xtracted from their prenatal electronic
ecords. This included maternal age;
arity; ethnicity; medical history (in-
luding chronic hypertension, diabetes
ellitus, antiphospholipid syndrome,
hrombophilia, and sickle cell disease);
bstetrical history (including previous
regnancy with preeclampsia); and
edications (including antihypertensive
edications). Maternal weight and
eightweremeasured and the bodymass
ndex (BMI) was calculated.
A single researcher (P.D.) performed
ll the ultrasound scans and the 3DPD
nalysis using Voluson 730 Expert (GE,
ilwaukee, WI). Following transab-
ominal measurements of the crown-
ump length (CRL) and NT, the utero-
lacental interface was identified, and
ower Doppler was applied avoiding the
etus. The power Doppler settings were
readjusted on all machines to allow
apture of weak signals that are common
n the intervillous space, in addition to
piral arteries, and settings were main-
ained constant for all cases: image qual-
ty at high 1, color gain at 1.6, pulse rep-
tition frequency at 0.6 kHz, and wall
otion filter at 50 Hz. All other Doppler
nd sonographic settings were at the
anufacturer default settings.
The 3Dvolume boxwas placed to con-
ain, in addition to the uteroplacental in-
erface, the placenta and the myome-
rium. After asking the patient to hold
er breath and remain still for 10 sec-
nds, a sweeping angle of 50° was used
hile the 3Dvolumewas acquired. In the
ultiplanar view, the A plane was ad-
usted using the Z-axis knob to bring the
teroplacental interface axis to a trans-
erse position in the center of the screen
ith the myometrium above and pla-
enta below that axis.
Optimal zooming (1.5-1.8) was
chieved and a spherical volume biopsy
ith a diameter of 2 cm was sampled.
ne pole was placed at the upper end of
he uteroplacental circulation and the
ther pole at the placenta (Figure 1). The
pherical volumewas then analyzed with
he virtual organ computer-aided analy-
is program (VOCAL; GE) to determine
he vascularization index (VI; the ratio
etween color voxels and total voxels ex- sressed in percentages), flow index (FI;
he sum of the color voxels’ signal inten-
ity divided by the number of color vox-
ls, quantified between 0 and 100), and
ascularization flow index (VFI; the sum
f color voxels’ signal intensity divided
y the total tissue voxels, quantified be-
ween 0 and 100).
The uterine arteries were then identi-
ed and the pulsatility index was mea-
FIGURE 1
Steps for the 3DPD indices of the U
he required steps to acquire the 3-dimensional
he uteroplacental interface (UPI, arrow) is identifi
, gray scale andB, power Doppler views. The int
, The 3DPD rendered view of the UPI and IVS.
nalysis option (GE, Milwaukee, WI) the sphere s
he uterine side of the uteroplacental interface
phere sampling is then activated, and F, the 3
phere biopsy.
DPD, 3-dimensional power Doppler; UPCS, uteroplacental circul
ar. First-trimester 3D power Doppler of uteroplacental circuured bilaterally. Because many placen- p
SEPTEMBER 2010 Americas at this stage of pregnancymay appear
o have both anterior and posterior im-
lantation sites, the placental location
as recorded according to sphere loca-
ion. For example, if a placenta appeared
o extend from the anterior to the poste-
ior uterinewall and the volumewas ren-
ered from the posterior part, the placenta
as recorded as posterior.Maternal serum
as sent for PAPP-A as part of the aneu-
S in first trimester
er Doppler indices of the UPCS in first trimester.
between the uterus (UT) and the placenta (PL) on
llous space (IVS) can be seen within the placenta.
r activation of the virtual organ computer-aided
ling method is chosen. D, One pole is placed at
the other at the fetal edge of the placenta. E,
indices are automatically calculated from the
space.
on space. Am J Obstet Gynecol 2010.PC
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latiloidy screening program.
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2Patientswere followed up to the end of
heir pregnancies and outcome data
ere compiled. The primary outcome
ata were whether patients developed
reeclampsia, defined by criteria out-
ined by the American College of Obstet-
ics and Gynecology. Briefly, patients
ad to have systolic blood pressures of
40 mm Hg or diastolic blood pressures
f 90mmHgor higher occurring after 20
eeks of gestation with proteinuria, de-
ned as urinary excretion of 0.3 g protein
r higher in a 24-hour urine specimen.14
he results of the 3D Doppler studies
ere not sharedwith the patients or their
roviders and did not affect themanage-
ent of their pregnancies.
tatistical analysis
AS version 9.1.3 (SAS Institute, Cary,
C) was used for statistical analysis.Ma-
ernal demographic characteristics for
oth the preeclampsia and control group
ere compared using the Student t test,
ilcoxon test, and Fisher’s exact tests.
he distribution of VI, FI, and VFI was
nalyzed with the Kolmogorov-Smirnov
est. The indices were plotted against
RL and correlation was evaluated by
he Pearson’s correlation test.
The 3DPD indices were compared be-
ween patients who developed pre-
clampsia and unaffected patients. Mul-
ivariate logistic regression analysis was
sed to determine which 3DPD indices
ignificantly predicted preeclampsia, ad-
usting for the maternal and gestational
haracteristics. Screening accuracy for
ach index was assessed through re-
eiver-operating characteristics (ROC)
urves. Overall accuracy was estimated
ith the area under the ROC curve and
ssociated 95% confidence interval (CI).
 .05 was considered statistically
ignificant.
ESULTS
wo hundred seventy-seven patients
ere enrolled. Eight patients (2.9%)
ad second-trimester spontaneous abor-
ions, 1 patient (0.4%) had a voluntary
ermination, and 10 patients (3.6%)
ere lost to follow-up. Of the remaining
58 patients, 24 (9.3%) developed pre-
clampsia and 234 (90.7%) patients did
ot. Among those with preeclampsia, 12 a
38.e3 American Journal of Obstetrics& Gynecolo50%) had severe preeclampsia.14 Three
f these had preeclampsia requiring de-
ivery prior to 34weeks, 9 had severe pre-
clampsia after 34 weeks’ gestation, and
patients of the latter grouphad eclamp-
ia. Two patients with preeclampsia
8.3%) had a small-for-gestational-age
SGA) newborn defined as birthweight
nder the 10th percentile15 and 14 pa-
ients (6.0%) had an SGAnewbornwith-
ut preeclampsia.
The demographic characteristics and
regnancy-related data of the groupwith
reeclampsia and the unaffected group
TABLE
Comparison of maternal and gesta
pregnancies with preeclampsia an
Characteristic
Unaffe
(n  2
Maternal age, y, mean (range)a 28.0
...................................................................................................................
Ethnicity, n (%)b
..........................................................................................................
Caucasian 26 (1
..........................................................................................................
African American 77 (3
..........................................................................................................
Hispanic 115 (4
..........................................................................................................
Asian/South Asian 14 (6
..........................................................................................................
Other 2 (1
..........................................................................................................
African American plus Hispanic 192 (8
...................................................................................................................
Risk factors for preeclampsia by
history, n (%)b,c
..........................................................................................................
Prior history of preeclampsia 13 (6
..........................................................................................................
Chronic hypertension 9 (4
..........................................................................................................
Diabetes mellitus 1 (0
..........................................................................................................
Sickle cell disease 1 (0
..........................................................................................................
Chronic renal disease 0 (0
..........................................................................................................
Systemic lupus erythematosus 1 (0
...................................................................................................................
Nulliparity, n (%)b 78 (3
...................................................................................................................
Mean BMI, kg/m2a 27.0
...................................................................................................................
BMI 30,b kg/m2 51 (2
...................................................................................................................
CRL at first screen, mmd 63.4
...................................................................................................................
Placental location (posterior)b 121 (5
...................................................................................................................
Mean gestational age at delivery,
wksa
39.1
...................................................................................................................
Mean birthweight, g (range)a 3300 (7
...................................................................................................................
Birthweight centile, n (range)a 43.2
...................................................................................................................
BMI, body mass index; CRL, crown-rump length; NS, not sign
a Wilcoxon test; b Fisher’s exact test; c Neither group had p
d Student t test.
Dar. First-trimester 3D power Doppler of uteroplacental cre compared in the Table. Patients who n
gy SEPTEMBER 2010eveloped preeclampsia had a signifi-
antly higher rate of risk factors by his-
ory and a higher BMI in the first trimes-
er. There was a larger proportion of
frican American and Hispanic patients
n the preeclampsia group (96%) as
omparedwith the control group (82%),
ut the difference was not statistically
ignificant. As expected, gestational age
t delivery and mean birthweight were
ignificantly lower in the preeclampsia
roup.
All 3DPD indices fit a Gaussian distri-
ution. A weak positive correlation was
al characteristics in
naffected controls
d Preeclampsia
(n  24) P value
–45) 26.3 (18–38) NS
..................................................................................................................
NS
..................................................................................................................
1 (4)
..................................................................................................................
10 (42)
..................................................................................................................
13 (54)
..................................................................................................................
0 (0)
..................................................................................................................
0 (0)
..................................................................................................................
23 (96)
..................................................................................................................
..................................................................................................................
5 (21)  .05
..................................................................................................................
6 (25)  .05
..................................................................................................................
2 (8)  .05
..................................................................................................................
0 (0) NS
..................................................................................................................
1 (4) NS
..................................................................................................................
0 (0) NS
..................................................................................................................
15 (62.5)  .05
..................................................................................................................
-45) 31.0 (10-49)  .05
..................................................................................................................
) 10 (42%)  .05
..................................................................................................................
.7-84) 63.0 (50.5-79.7) NS
..................................................................................................................
) 17 (71%) NS
..................................................................................................................
.3-41.4) 37.3 (30.4-40.9)  .05
..................................................................................................................
–4625) 2813 (954–4600)  .05
..................................................................................................................
100) 32.8 (5–94)  .05
..................................................................................................................
t.
ts with antiphospholipid antibody syndrome or thrombophilia;
lation space. Am J Obstet Gynecol 2010.tion
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www.AJOG.org Imaging ResearchRL, but the correlations did not reach
tatistical significance (VI, r 0.098; FI,
 0.110; VFI, r  0.113, P  NS). All
rst-trimester 3DPD flow indices were
ignificantly lower in patients who sub-
equently developed preeclampsia as
ompared with unaffected pregnancies
mean SD, preeclampsia VI 17.0
.2 vs no preeclampsia VI 23.7 10.6,
 .001; preeclampsia FI  47.0  6.9
s no preeclampsia FI 52.6 8.3, P
001; preeclampsia VFI 8.3 3.8 vs no
reeclampsia VFI  12.9  7.1, P 
002). Figure 2 illustrates themedian, in-
erquartile range, and range of VI, FI,
nd VFI in the preeclampsia and unaf-
ected groups.
First-trimester PAPP-A and UAPI
ere not found to be significantly differ-
nt between patientswhodeveloped pre-
clampsia and those who did not (1.22
ultiple of the medians [MOM]; range,
.26–3.13 vs 1.33 MOM; range, 0.26–
.05; P  .443 for PAPP-A and 1.86
OM; range, 0.13–3.84 vs 1.78 MOM;
ange, 0.1–9.37; P .331 for UAPI).
The following regression equations
ere developed for each, adjusted for
thnicity, BMI, and placental location to
redict preeclampsia.
isk of preeclampsia using VI
 Y  3.9932  0.0507  FI 
.9236  (1 if race is African American
rHispanic; 0 if any other race) 0.0985
BMI  0.4399  (1 if anterior; 0 if
FIGURE 2
VI, FI, and VFI in preeclampsia and
ox and whisker plot of VI, FI, and VFI in patients
ange and the whisker represents the variables r
I, flow index; VFI, vascularization flow index; VI, vascularization in
ar. First-trimester 3D power Doppler of uteroplacental circuther placental location)  1.3925 (1 if Culliparous; 0 if none); R2 0.2075, P
.004.
isk of preeclampsia using FI
5.7049 0.0458 VFI 0.9952
(1 if race is African American or His-
anic; 0 if any other race)  0.1085 
MI 0.7944 (1 if anterior; 0 if other
lacental location) 1.2387(1 if nullip-
rous; 0 if none); R2 0.1956,P .0002.
isk of preeclampsia using VFI
5.6145 0.0853VI 0.9506
1 if race is African American or His-
anic; 0 if any other race)  0.1040 
MI 0.7197 (1 if anterior; 0 if other
lacental location)  1.2472*(1 if nul-
iparous; 0 if none); R2  0.2120, P 
0002.
PAPP-A and UAPI were assessed in
he logistic regression models, and the
rediction of preeclampsia was not im-
roved by including these variables in
he model.
Figure 3 shows the ROC curves for the
rediction of preeclampsia by each of the
ow parameters. The area under curve
AUC) for VI, FI, and VFI was 78.9%
95% CI, 70.2–87.4%), 77.6% (95% CI,
8.1–87.0%), and 79.6% (95%CI, 71.2–
7.9%), respectively. In comparison, the
UC for PAPP-A and UAPI was 75.5%
95% CI, 64.7–86.2%) and 74.5% (95%
I, 63.0–85.9%), respectively.
For a 10% false-positive rate, the de-
ection rates for all cases of preeclampsia
ould have been 36.4% for VI (95%
affected controls
subsequently developed preeclampsia and unaf
e.
on space. Am J Obstet Gynecol 2010.I, 17.24–59.3%), 20.8% for FI (95%CI, U
SEPTEMBER 2010 Americ.2–40.3%) and 36.4% for VFI (95%CI,
7.2–59.3%). In comparison, the detec-
ion rates of PAPP-A and UAPI for the
ame false-positive rate would have been
0.9% and 40.0%, respectively.
In the 12 women who subsequently
eveloped severe preeclampsia, the first-
rimester 3DPD indices were signifi-
antly lower than in those who did not
mean  SD, 14.66  7.42 vs 23.77 
1.58 for VI, P .0021; 44.65 6.96 vs
2.65 8.33 for FI, P .0013; and 6.93
4.30 vs 12.91  7.12 for VFI, P 
0005). The ROC AUC for VI, FI, and
FI for the prediction of severe pre-
clampsia was 83.2% (95% CI, 77.9–
7.7%), 80.0% (95% CI, 74.5–84.9%),
nd 83.4% (95% CI, 78.1–87.8%), re-
pectively. Although the ROC AUC ap-
ears to be greater for all indices for se-
ere preeclampsia as compared with all
ases of preeclampsia, the differences
ere not statistically significant.
OMMENT
reeclampsia complicates approximately
-7% of pregnancies and is a leading
ause of maternal death worldwide.16
he pathophysiological processes that
ccur in the UPCS and lead to the disor-
er begin early in pregnancy. Therefore,
t is imperative that any screening or
otentially prophylactic intervention
hould be aimed at the first trimester. In
his study, we explored a novel ultra-
onographic tool to investigate the
ed controls. The box represents the interquartileun
who fect
ang
dex.
latiPCS in the first trimester. Our findings
an Journal of Obstetrics& Gynecology 238.e4
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238.e5 American Journal of Obstetrics& Gynecology SEPTEMBER 2010emonstrate that in women who subse-
uently develop preeclampsia, 3DPD in-
ices at 10 weeks 4 days to 13 weeks 6
ays of gestation are significantly lower
han in unaffected pregnancies.
These data are consistent with the cur-
ent knowledge of the pathophysiology
f the disorder. 3DPD indices were sug-
ested by Pairleitner et al11 to correlate
ith hemovascular parameters. VI was
ostulated to represent vascular density,
I to represent corpuscle volume within
he blood vessels, and VFI to represent
orpuscle volume within a tissue.
These assumptions were supported by
orrelating the flow indices with immu-
ohistological assessment of the vascula-
ure in different tissues.17,18 Although
he intervillous space is not comprised of
lood vessels but blood-filled lacunae,
he 3DPD technology when set up to
apture low velocity flow will probably
erceive the significant lacunae in the in-
ervillous space as a vascular space.
onetheless, in a recent elegant in vitro
tudy, Raine-Fenning et al19 showed that
lthough a linear correlation exists be-
ween VI/VFI and vascularity and be-
ween FI and corpuscle volume, these
orrelations are more complex than pre-
iously suggested.
Our findings further suggest that
easurement of VI, FI, and VFI in early
regnancy may provide an effective
rst-trimester screening method for
his pregnancy-associated disorder. The
UCs for all 3 parameters in the current
tudy were greater than previously
eported findings on uterine artery
ulsatility4,20 or resistive5 indexes and
APP-A8 as predictors for all cases of
reeclampsia and comparable with the
redictive value of PAPP-A and UAPI in
he current study.
The main advantage of the 3DPD ap-
roach lies in its direct but noninvasive
OC curves for VI (dashed line; AUC, 78.9%) FI
dotted line; AUC, 77.6%) and VFI (solid line;
UC, 79.6%) for the prediction of preeclampsia.
UC, area under the curve; FI, flow index; ROC, receiver operating
haracteristic; VFI, vascularization flow index; VI, vascularization
ndex.
ar. First-trimester 3D power Doppler of uteroplacental
irculation space. Am J Obstet Gynecol 2010.FIGURE 3
ROC curves for VI, FI, and VFI
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www.AJOG.org Imaging Researchbility to study hemovascular differences
n a key area for the development of pre-
clampsia. The uterine artery pulsatility
ndex, the most commonly studied
onographic tool for the prediction of
reeclampsia, is an indirect tool and
ikely to be useful in the prediction of
evere and early preeclampsia requiring
elivery prior to 34 weeks’ gestation. Al-
hough the latter approach is expected to
apture most of the severe cases, there is
o doubt that significant maternal and
etal morbidity can occur beyond 34
eeks’ gestation.21-23 Therefore, we be-
ieve that screening methods that iden-
ify a broader group of patients at risk for
reeclampsia, such as patients with se-
ere preeclampsia at any gestational age,
hould be searched for.
Our findings indicate that the sensitiv-
ty of the 3DPD approach for early
creening for preeclampsia is too low
o provide a single-marker prediction
odel. Nevertheless, this method carries
he potential to contribute to a predic-
ion model in combinations with other
elected ultrasonographic and biochem-
cal markers. Such an integrated model
emains to be investigated.
The current study has several limita-
ions. The first is a lack of universal stan-
ardization of volume sampling ap-
roach and equipment settings. We
hose to use a sphere biopsymodality for
DPD volume sampling. Other investi-
ators, studying the uteroplacental and
ntervillous space between 5 and 12
eeks’ gestation, used either free-hand
olume sampling24 or the sphere biopsy
pproach.25 Bothmethods were demon-
trated to be reproducible with good in-
ra- and interobserver agreement.24,25
In our experience, the sphere biopsy
odality is simpler to perform when
canning placentas between 11 and 14
eeks’ gestation and allows for main-
aining similar sample volumes between
atients. Although recent in vitro studies
ave made advancements in determin-
ng the effects of different gain, power,
ulse repetition frequencies, and wall
otion filter settings on the power
oppler signal,26,27 to date there are no
n vivo data to support optimized set-
ings for the study of the UPCS and par-
icularly of the intervillous component. Cevertheless, it is our impression, also
upported by others,12,24,25 that as long
s the same settings are maintained be-
ween patients and between studies, re-
roducibility of the results will be
ossible.
Second, it is recognized that the power
oppler intensity decreases as the dis-
ance between the transducer and the
arget object increases, a phenomenon
alled attenuation. As a result, variables
uch as abdominal girth andplacental lo-
ation may impact the 3DPD measure-
ents. In this study, we used logistic re-
ression to adjust the 3DPD indices for
MI andplacental location. It is possible,
owever, that other approaches like the
ctual distance between the probe and
he spherical center will prove to be a
etter adjustment variable than BMI and
lacental location. This aspect was not
nvestigated in this study, and future
tudies are needed to substantiate its
ignificance.
Finally, there is a concern that exists
ith the use of power Doppler imaging
n the first trimester. Yet, with the sug-
ested methodology, the sound waves
re not directed toward the fetus. Fur-
hermore, the application of the power
oppler with the volume acquisition
oes not exceed 10-15 seconds.
In summary, 3DPD emerges as a valu-
ble noninvasive tool to studyphysiolog-
cal changes that occur in theUPCS early
n pregnancy. It appears that during the
rst trimester, patients who subse-
uently develop preeclampsia have
ower 3DPD indices in this key space.
sing this methodology has the poten-
ial to improve screening for preeclamp-
ia in the future, possibly in a combina-
ion of selected predictive markers. f
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